WELCOME TO STERISIS
What is the Key to Better Infection Prevention? Identify Infectious Agents Faster and More Frequently
AMS' comprehensive surveillance program uses quarterly non-invasive PCR testing for 37 distinct respiratory pathogens plus an antibiotic resistance gene test along with infection prevention virtual rounding of the resident EHR. Armed with accurate test results and live clinical analytics, the AMS team supports clinical staff in reducing the spread of infectious diseases and combat overprescribing of unnecessary antibiotics within the facility. Our team works with your team to provide extra oversight and care while never overstepping our role as your infection prevention mentor.
Features
AMS Infection Preventionist assigned to your facility
24/7 remote live monitoring of resident EHRs
Infectious Disease Outbreak Alerts
Quarterly PCR testing of residents resulted through a proprietary infectious disease analytics tool, making facility-specific infection prevention recommendations
Step-by-step, week-by-week infection prevention QAPI program management
Mentorship and educational services for clinical leadership
Access to AMS Medical Director
Clinical Testing
Non-invasive respiratory testing for 37 distinct pathogens at regular intervals
Same test also checks for antibiotic resistance genes
Optional as-needed testing also available to identify GI, UTI, wound, nail, and blood risks
Labs recommended by AMS conduct Polymerase Chain Reaction (PCR) molecular testing that is 99.9% accurate
Treatment recommendations based on test results and infectious disease analytics
Program Benefits
Infection risk reduction
Early detection of potential infectious disease outbreaks (download our most recent results here)
Infection prevention education and training for staff
Access to infection prevention experts
Infection risk analytics
Reduces unnecessary antibiotics
Fully integrated into QAPI
Supports F880 infection surveillance
Meets CDC NHSN's definition of “Comprehensive Surveillance"
Improve resident census
Improve patient care
AMS has been reducing infection risks in nursing homes since 2018. For additional information about STERISIS or to learn about other programs, clinical research, regulatory IPC or Antimicrobial Stewardship requirements, advice from colleagues, and more, please visit our Resource Center.